Navigation Links
Two Genes May Determine How Well MS Patients Do
Date:9/11/2009

Study in mice provides clues to variations in disease progression

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.



-- Randy Dotinga



SOURCE: Mayo clinic, news release, Sept. 11, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
3. New Database to Help Speed Search for Bipolar Disorder Genes
4. Is Perfect Pitch All in the Genes?
5. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
6. Genes Boost Risk for Rheumatoid Arthritis, Lupus
7. The genes involved in rheumatoid arthritis identified
8. If you think cancer genes are simple, you dont know JAK
9. Test for lung cancer looks for discomforting quiet among protective genes
10. Hushed Genes Might Mean Higher Lung Cancer Risk
11. EURYI project to understand how the brain wires during embryogenesis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two Genes May Determine How Well MS Patients Do
(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke ... its ANCD BRAIN device as the product advances towards regulatory and clinical phases. ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura ... the achievement of Cisco Select certification and SMB specialization. Altura is now ... , In earning the Select Certification, Altura fulfilled the training and exam ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... consumers can save an average of 70% when buying medication online from Canadian ... are available when purchasing from other countries. The report (chart below) compares U.S. ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article in ... teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their primitive ... been used to remove decayed dental matter, and that teeth were then filled with ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... -- Astute Medical, Inc., developer of biomarkers for better healthcare, ... the 2017 National Kidney Foundation (NKF) Spring Clinical ... 22. Physicians will present data on two biomarkers, ... acute kidney injury (AKI) during the management of patients ... Elevated levels of TIMP-2 and IGFBP-7 have been shown ...
(Date:4/18/2017)... , April 18, 2017  Spero Therapeutics, LLC, a ... treatment of bacterial infections, will present preclinical data supporting ... of multidrug resistant (MDR) Gram-negative infections at the 27th ... April 22-25, 2017 in Vienna, Austria ... ...
Breaking Medicine Technology: